Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 174.30 EUR | +0.29% |
|
+1.81% | -17.00% |
| 07-28 | SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein | ZD |
| 07-24 | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| Market Cap | 16.96B 19.54B 15.88B 14.52B 27.38B 1,859B 27.79B 186B 72.9B 932B 73.35B 71.75B 3,096B | P/E 2026 * |
44.9x | P/E 2027 * | 34.7x |
|---|---|---|---|---|---|
| Enterprise Value | 18.97B 21.86B 17.76B 16.25B 30.63B 2,080B 31.09B 208B 81.54B 1,042B 82.05B 80.26B 3,463B | EV / Sales 2026 * |
6.07x | EV / Sales 2027 * | 5.4x |
| Free-Float |
28.47% | Yield 2026 * |
0.49% | Yield 2027 * | 0.59% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +0.29% | ||
| 1 week | +1.81% | ||
| Current month | +4.56% | ||
| 1 month | -3.27% | ||
| 3 months | +7.33% | ||
| 6 months | -3.91% | ||
| Current year | -17.00% |
| 1 week | 166 |  | 177.6 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.29% | +1.81% | +2.59% | -35.35% | 19.52B | |
| +2.13% | -0.04% | -17.39% | +0.29% | 183B | |
| -0.08% | -1.85% | -4.18% | +2.24% | 110B | |
| +2.46% | +2.01% | +11.17% | +75.37% | 61.72B | |
| -1.64% | +7.20% | +39.25% | +56.58% | 54.98B | |
| +3.76% | +5.15% | +0.10% | -34.61% | 47.02B | |
| -5.88% | -13.90% | - | - | 32.16B | |
| +0.44% | +10.49% | +10.02% | -31.01% | 31.19B | |
| -0.69% | +3.30% | +45.94% | -7.06% | 24.7B | |
| -0.40% | -1.30% | +3.53% | +2.55% | 22.68B | |
| Average | -0.53% | +1.41% | +10.11% | +3.22% | 58.7B | |
| Weighted average by Cap. | -0.33% | +0.24% | +1.42% | +8.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.6B 2.93B 2.68B 5.05B 343B 5.12B 34.26B 13.44B 172B 13.52B 13.22B 571B | 3.47B 3.99B 3.24B 2.97B 5.6B 380B 5.68B 37.98B 14.9B 190B 14.99B 14.66B 633B |
| Net income | 376M 434M 352M 322M 608M 41.25B 617M 4.12B 1.62B 20.67B 1.63B 1.59B 68.68B | 480M 554M 450M 411M 776M 52.67B 787M 5.27B 2.07B 26.39B 2.08B 2.03B 87.7B |
| Net Debt | 2.01B 2.32B 1.88B 1.72B 3.25B 220B 3.3B 22.04B 8.64B 110B 8.7B 8.51B 367B | 1.77B 2.04B 1.66B 1.51B 2.86B 194B 2.9B 19.39B 7.6B 97.16B 7.65B 7.48B 323B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | €174.30 | +0.29% | 55,050 |
| 26-08-05 | €173.80 | +0.52% | 62,230 |
| 26-08-04 | €172.90 | +0.58% | 74,728 |
| 26-08-03 | €171.90 | +3.12% | 65,593 |
| 26-07-31 | €166.70 | -2.00% | 137,690 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
